April 19, 2018 / 12:05 PM / a month ago

BRIEF-VBI Vaccines Announces Completion Of Enrollment In Protect Phase 3 Clinical Study For Sci-B-Vac Hepatitis B Vaccine

April 19 (Reuters) - VBI Vaccines Inc:

* VBI VACCINES ANNOUNCES COMPLETION OF ENROLLMENT IN PROTECT PHASE 3 CLINICAL STUDY FOR SCI-B-VAC® HEPATITIS B VACCINE

* VBI VACCINES INC - TOPLINE DATA FROM PROTECT STUDY ARE EXPECTED MID-YEAR 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below